Gill Levitt

7.0k total citations · 2 hit papers
57 papers, 3.6k citations indexed

About

Gill Levitt is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Gill Levitt has authored 57 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pediatrics, Perinatology and Child Health, 21 papers in Public Health, Environmental and Occupational Health and 18 papers in Molecular Biology. Recurrent topics in Gill Levitt's work include Childhood Cancer Survivors' Quality of Life (33 papers), Renal and related cancers (17 papers) and Acute Lymphoblastic Leukemia research (16 papers). Gill Levitt is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (33 papers), Renal and related cancers (17 papers) and Acute Lymphoblastic Leukemia research (16 papers). Gill Levitt collaborates with scholars based in United Kingdom, United States and Netherlands. Gill Levitt's co-authors include William H. Wallace, Roderick Skinner, Victoria Cornelius, Peter Canney, L. A. Smith, Alison Jones, Chris Plummer, Mark Verrill, Catherine Bull and Ian Sullivan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Gill Levitt

56 papers receiving 3.5k citations

Hit Papers

Cardiotoxicity of anthracycline agents for the treatment ... 2010 2026 2015 2020 2010 2015 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gill Levitt United Kingdom 33 1.8k 1.1k 1.1k 817 808 57 3.6k
Liton Francisco United States 34 1.5k 0.8× 1.2k 1.1× 605 0.6× 529 0.6× 1.1k 1.3× 109 3.9k
Foppe Oldenburger Netherlands 24 1.1k 0.7× 560 0.5× 368 0.3× 495 0.6× 475 0.6× 45 2.3k
Uma H. Athale Canada 31 1.2k 0.7× 1.1k 1.0× 931 0.9× 449 0.5× 627 0.8× 126 3.5k
Craig A. Hurwitz United States 31 1.2k 0.7× 1.4k 1.3× 559 0.5× 626 0.8× 847 1.0× 64 3.6k
Sheri L. Spunt United States 44 1.5k 0.9× 1.1k 1.0× 648 0.6× 970 1.2× 1.6k 1.9× 193 6.2k
Caro C.E. Koning Netherlands 24 923 0.5× 591 0.5× 362 0.3× 187 0.2× 527 0.7× 50 2.2k
Jacqueline J. Loonen Netherlands 26 880 0.5× 549 0.5× 641 0.6× 224 0.3× 442 0.5× 106 1.9k
Marshall A. Schorin United States 23 1.6k 0.9× 1.6k 1.4× 1.2k 1.2× 342 0.4× 714 0.9× 43 3.1k
P.A. Voûte Netherlands 44 1.5k 0.9× 816 0.7× 1.2k 1.1× 2.4k 3.0× 1.4k 1.7× 106 7.1k
Tara O. Henderson United States 37 2.2k 1.2× 1.5k 1.4× 130 0.1× 359 0.4× 1.3k 1.6× 139 4.1k

Countries citing papers authored by Gill Levitt

Since Specialization
Citations

This map shows the geographic impact of Gill Levitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gill Levitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gill Levitt more than expected).

Fields of papers citing papers by Gill Levitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gill Levitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gill Levitt. The network helps show where Gill Levitt may publish in the future.

Co-authorship network of co-authors of Gill Levitt

This figure shows the co-authorship network connecting the top 25 collaborators of Gill Levitt. A scholar is included among the top collaborators of Gill Levitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gill Levitt. Gill Levitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mulder, Renée L., Melissa M. Hudson, Smita Bhatia, et al.. (2020). Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group. Journal of Clinical Oncology. 38(35). 4194–4207. 44 indexed citations
2.
Frobisher, Clare, Adam Glaser, Gill Levitt, et al.. (2017). Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up. British Journal of Cancer. 117(11). 1723–1731. 38 indexed citations
3.
Mulder, Renée L., Helena J. H. van der Pal, Gill Levitt, et al.. (2015). Transition guidelines: An important step in the future care for childhood cancer survivors. A comprehensive definition as groundwork. European Journal of Cancer. 54. 64–68. 25 indexed citations
4.
Spreafico, Filippo, Monica Terenziani, Marry M. van den Heuvel‐Eibrink, et al.. (2014). Why should survivors of childhood renal tumor and others with only one kidney be denied the chance to play contact sports?. Expert Review of Anticancer Therapy. 14(4). 363–366. 5 indexed citations
6.
Chowdhury, Tanzina, et al.. (2013). Late Complications of Cancer in Childhood and Adolescence. 9(1). 52–52. 3 indexed citations
8.
Pritchard‐Jones, Kathy, V. Moroz, Gordan Vujanić, et al.. (2012). Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial. Annals of Oncology. 23(9). 2457–2463. 62 indexed citations
9.
Stoneham, Simon, Gordan Vujanić, L Boccon-Gibod, et al.. (2009). CLEAR CELL SARCOMA OF THE KIDNEY (CCSK) - COMBINED 20 YEAR EXPERIENCE OF THERAPUETIC OUTCOMES FROM UNITED KINGDOM (UK) AND FRANCE. UCL Discovery (University College London). 1 indexed citations
10.
Stoneham, Sarah J., V. V. Moroz, Gordan Vujanić, et al.. (2009). Clear cell sarcoma of the kidney (CCSK) - combined 20 year experience of therapuetic outcomes from United Kingdom (UK) and France [Abstract]. ORCA Online Research @Cardiff (Cardiff University). 4 indexed citations
11.
Anderson, Richard A., A. G. M. Weddell, Helen Spoudeas, et al.. (2008). Do doctors discuss fertility issues before they treat young patients with cancer?. Human Reproduction. 23(10). 2246–2251. 104 indexed citations
12.
Levitt, Gill, et al.. (2007). A review of long-term follow-up for survivors of childhood cancer. European Journal of Cancer. 43(12). 1781–1790. 23 indexed citations
13.
Taylor, Aliki, Mike Hawkins, Helena Davies, et al.. (2004). Long‐term follow‐up of survivors of childhood cancer in the UK. Pediatric Blood & Cancer. 42(2). 161–168. 64 indexed citations
14.
Sørensen, Keld E., Gill Levitt, Catherine Bull, I Dørup, & Ian D. Sullivan. (2003). Late anthracycline cardiotoxicity after childhood cancer. Cancer. 97(8). 1991–1998. 162 indexed citations
15.
Jenney, Meriel & Gill Levitt. (2002). The quality of survival after childhood cancer. European Journal of Cancer. 38(9). 1241–1250. 23 indexed citations
16.
Wallace, William H., A. Blacklay, Christine Eiser, et al.. (2001). Developing strategies for long term follow up of survivors of childhood cancer. BMJ. 323(7307). 271–274. 175 indexed citations
17.
Levitt, Gill. (1999). CARDIOPROTECTION. British Journal of Haematology. 106(4). 860–869. 8 indexed citations
18.
Pritchard, Jon, et al.. (1998). Radiotherapy omitted in the treatment of selected children under 3 years of age with stage III favorable histology Wilms tumor. Medical and Pediatric Oncology. 31(3). 150–152. 8 indexed citations
19.
Sørensen, K., Gill Levitt, Catherine Bull, J M Chessells, & Ian Sullivan. (1997). Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.. Journal of Clinical Oncology. 15(1). 61–68. 131 indexed citations
20.
Pein, F, Ross Pinkerton, M F Tournade, et al.. (1993). Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.. Journal of Clinical Oncology. 11(8). 1478–1481. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026